| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI802046N |
| P698 | PubMed publication ID | 19216516 |
| P50 | author | Liping Yu | Q55189535 |
| P2093 | author name string | Edward T Olejniczak | |
| John E Harlan | |||
| Philip J Hajduk | |||
| Karl Walter | |||
| Robert W Johnson | |||
| Rohinton Edalji | |||
| Stefan Barghorn | |||
| Heinz Hillen | |||
| Paul L Richardson | |||
| Ulrich Ebert | |||
| Boris Labkovsky | |||
| Thomas F Holzman | |||
| Larry Solomon | |||
| Diane Bartley | |||
| Ana Pereda Lopez | |||
| Laura Miesbauer | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1870-1877 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | Structural characterization of a soluble amyloid beta-peptide oligomer | |
| P478 | volume | 48 |
| Q57182797 | (R)-α-trifluoromethylalanine containing short peptide in the inhibition of amyloid peptide fibrillation |
| Q27684839 | A Fibril-Like Assembly of Oligomers of a Peptide Derived from β-Amyloid |
| Q46319427 | A Hexamer of a Peptide Derived from Aβ16-36. |
| Q45398214 | A Strategy for Designing a Peptide Probe for Detection of β‐Amyloid Oligomers |
| Q43066105 | A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta |
| Q28740910 | A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques |
| Q44009111 | A folding transition underlies the emergence of membrane affinity in amyloid-β. |
| Q44368568 | A hexameric peptide barrel as building block of amyloid-β protofibrils |
| Q47340488 | A peptide probe for detection of various beta-amyloid oligomers |
| Q37922207 | Aggregation of amyloids in a cellular context: modelling and experiment |
| Q36484002 | Allosteric stabilization of the amyloid-β peptide hairpin by the fluctuating N-terminal |
| Q36330092 | Alzheimer's amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity |
| Q37636545 | Alzheimer's disease: synaptic dysfunction and Abeta |
| Q35050571 | Alzheimer's protective A2T mutation changes the conformational landscape of the Aβ₁₋₄₂ monomer differently than does the A2V mutation |
| Q33597771 | Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal |
| Q39418248 | Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization |
| Q39437881 | Amyloid beta: structure, biology and structure-based therapeutic development |
| Q35586308 | Amyloid polymorphism: structural basis and neurobiological relevance |
| Q33893017 | Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies |
| Q90292784 | Amyloid-β fibrils assembled on ganglioside-enriched membranes contain both parallel β-sheets and turns |
| Q28534463 | Amyloid-β protofibrils: size, morphology and synaptotoxicity of an engineered mimic |
| Q38748337 | An Account of Amyloid Oligomers: Facts and Figures Obtained from Experiments and Simulations |
| Q53362964 | An infrared sensor analysing label-free the secondary structure of the Abeta peptide in presence of complex fluids. |
| Q35590968 | Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment |
| Q35688837 | Antiparallel β-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-β Peptides When They Form 150-kDa Oligomers. |
| Q55007427 | Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism. |
| Q42584937 | Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways |
| Q41637828 | Assembly of Peptides Derived from β-Sheet Regions of β-Amyloid |
| Q24633954 | Atomic-Level Characterization of the Ensemble of the Aβ(1–42) Monomer in Water Using Unbiased Molecular Dynamics Simulations and Spectral Algorithms |
| Q53352144 | Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies. |
| Q39302920 | Aβ(1-42) assembly in the presence of scyllo-inositol derivatives: identification of an oxime linkage as important for the development of assembly inhibitors. |
| Q96431381 | Aβ(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage |
| Q30152727 | Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments |
| Q42237530 | Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution |
| Q37888775 | BRICHOS domain associated with lung fibrosis, dementia and cancer--a chaperone that prevents amyloid fibril formation? |
| Q50546707 | Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states. |
| Q38472553 | Beta-amyloid oligomers: recent developments |
| Q30156038 | Beta‐barrel models of soluble amyloid beta oligomers and annular protofibrils |
| Q52355802 | Binding Modes of Phthalocyanines to Amyloid β Peptide and Their Effects on Amyloid Fibril Formation. |
| Q38016898 | Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease |
| Q57035312 | Biomolecular Assemblies: Moving from Observation to Predictive Design |
| Q35547479 | Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity. |
| Q38103603 | Calcium channel blockers and dementia |
| Q27667459 | Characteristics of Amyloid-Related Oligomers Revealed by Crystal Structures of Macrocyclic β-Sheet Mimics |
| Q44064170 | Characterization of the internal dynamics and conformational space of zinc-bound amyloid β peptides by replica-exchange molecular dynamics simulations |
| Q41276334 | Chemical probes that selectively recognize the earliest Aβ oligomers in complex mixtures. |
| Q41637849 | Coassembly of Peptides Derived from β-Sheet Regions of β-Amyloid |
| Q84615371 | Combining conformational sampling and selection to identify the binding mode of zinc-bound amyloid peptides with bifunctional molecules |
| Q34657052 | Comparative studies of disordered proteins with similar sequences: application to Aβ40 and Aβ42 |
| Q52600172 | Controlling the Oligomerization State of Aβ-Derived Peptides with Light. |
| Q48301050 | Cooperative structural transitions in amyloid-like aggregation |
| Q36971689 | Copper ligation to soluble oligomers of the English mutant of the amyloid-β peptide yields a linear Cu(I) site that is resistant to O2 oxidation |
| Q47570197 | Coupling of Zinc-Binding and Secondary Structure in Nonfibrillar Aβ40 Peptide Oligomerization. |
| Q48314753 | Covalent Tethering and Residues with Bulky Hydrophobic Side Chains Enable Self-Assembly of Distinct Amyloid Structures |
| Q27666598 | Crystal structure of the amyloid-β p3 fragment provides a model for oligomer formation in Alzheimer's disease |
| Q34860628 | Cu K-edge X-ray absorption spectroscopy reveals differential copper coordination within amyloid-β oligomers compared to amyloid-β monomers |
| Q33946695 | Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. |
| Q36939730 | Differences in β-strand populations of monomeric Aβ40 and Aβ42. |
| Q34440267 | Effect of mid-infrared free-electron laser irradiation on refolding of amyloid-like fibrils of lysozyme into native form |
| Q38272707 | Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation |
| Q34004146 | Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: a model system to study neurotoxicity in Alzheimer's disease |
| Q52672253 | Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. |
| Q53208723 | Engineering of a peptide probe for β-amyloid aggregates. |
| Q37280507 | Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy |
| Q48100081 | Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies |
| Q35813445 | High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification |
| Q33808009 | High-resolution conformation and backbone dynamics of a soluble aggregate of apomyoglobin119. |
| Q27677103 | High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. |
| Q27675368 | Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallography |
| Q33984677 | Identification of novel short peptide inhibitors of soluble 37/48 kDa oligomers of amyloid β42. |
| Q44640299 | Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide |
| Q34224651 | Inhibition of aggregation of amyloid β42 by arginine-containing small compounds |
| Q34990429 | Insight into amyloid structure using chemical probes |
| Q28478284 | Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide |
| Q35448326 | Interaction of amyloid inhibitor proteins with amyloid beta peptides: insight from molecular dynamics simulations |
| Q35643870 | Intra-membrane oligomerization and extra-membrane oligomerization of amyloid-β peptide are competing processes as a result of distinct patterns of motif interplay. |
| Q35051250 | Isolating toxic insulin amyloid reactive species that lack β-sheets and have wide pH stability |
| Q40692757 | Isotope-edited FTIR reveals distinct aggregation and structural behaviors of unmodified and pyroglutamylated amyloid β peptides |
| Q34043216 | Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation. |
| Q38666447 | Lipid composition influences the release of Alzheimer's amyloid β-peptide from membranes. |
| Q58568468 | Liquid and Hydrogel Phases of PrP Linked to Conformation Shifts and Triggered by Alzheimer's Amyloid-β Oligomers |
| Q28592890 | Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease |
| Q34624898 | Macrocyclic β-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide |
| Q30819640 | Measuring translational diffusion coefficients of peptides and proteins by PFG-NMR using band-selective RF pulses |
| Q37871074 | Mechanisms of amyloid fibril formation--focus on domain-swapping |
| Q34211231 | Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats |
| Q35885686 | Membrane-Induced Dichotomous Conformation of Amyloid β with the Disordered N-Terminal Segment Followed by the Stable C-Terminal β Structure |
| Q37729567 | Microsecond molecular dynamics simulation of Aβ42 and identification of a novel dual inhibitor of Aβ42 aggregation and BACE1 activity |
| Q38223686 | Misfolding of amyloidogenic proteins and their interactions with membranes |
| Q34474466 | Modeling amyloid-beta as homogeneous dodecamers and in complex with cellular prion protein |
| Q39271013 | Modulation of amyloid-β 1-42 structure and toxicity by proline-rich whey peptides. |
| Q36771721 | Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease |
| Q28066391 | Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance |
| Q27674499 | Molecular basis for amyloid- polymorphism |
| Q36015420 | Molecular engineering of a secreted, highly homogeneous, and neurotoxic aβ dimer |
| Q36569893 | Monomeric Aβ(1-40) and Aβ(1-42) Peptides in Solution Adopt Very Similar Ramachandran Map Distributions That Closely Resemble Random Coil |
| Q36118412 | NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. |
| Q28572007 | Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly. |
| Q36153110 | Native chemical ligation of thioamide-containing peptides: development and application to the synthesis of labeled α-synuclein for misfolding studies |
| Q30998279 | Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions |
| Q30426229 | Novel insights into protein misfolding diseases revealed by ion mobility-mass spectrometry |
| Q26749061 | Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds |
| Q34299359 | Polymorphic C-terminal β-Sheet Interactions Determine the Formation of Fibril or Amyloid β-derived Diffusible Ligand-like Globulomer for the Alzheimer Aβ42 Dodecamer |
| Q33936902 | Polymorphic structures of Alzheimer's β-amyloid globulomers. |
| Q35311079 | Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide |
| Q34059772 | Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape |
| Q37454220 | Polymorphism of fibrillar structures depending on the size of assembled Aβ17-42 peptides |
| Q37731524 | Polymorphism of oligomers of a peptide from β-amyloid |
| Q41657894 | Probing amylin fibrillation at an early stage via a tetracysteine-recognising fluorophore. |
| Q37913546 | Protein engineering to stabilize soluble amyloid β-protein aggregates for structural and functional studies |
| Q35108312 | RNA aptamer probes as optical imaging agents for the detection of amyloid plaques. |
| Q89411641 | Recent Insights on Alzheimer's Disease Originating from Yeast Models |
| Q34999535 | Recent advances in our understanding of neurodegeneration |
| Q36772928 | Resolution of oligomeric species during the aggregation of Aβ1-40 using (19)F NMR. |
| Q36150710 | Role of β-hairpin formation in aggregation: the self-assembly of the amyloid-β(25-35) peptide. |
| Q36138981 | SDS-PAGE analysis of Aβ oligomers is disserving research into Alzheimer´s disease: appealing for ESI-IM-MS |
| Q33744974 | Selection of Peptide Inhibitors of Soluble Aβ1-42Oligomer Formation by Phage Display |
| Q46523542 | Self-assembly of the full-length amyloid Aβ42 protein in dimers |
| Q53351910 | Significant structural differences between transient amyloid-β oligomers and less-toxic fibrils in regions known to harbor familial Alzheimer's mutations. |
| Q39987923 | Size-dependent neurotoxicity of beta-amyloid oligomers. |
| Q35327629 | Solid-state NMR studies of amyloid fibril structure |
| Q41443925 | Solution NMR studies of recombinant Aβ(1-42): from the presence of a micellar entity to residual β-sheet structure in the soluble species. |
| Q30571951 | Spatial structure of heptapeptide Aβ(16-22) (beta-amyloid Aβ(1-40) active fragment) in solution and in complex with a biological membrane model |
| Q37707886 | Square channels formed by a peptide derived from transthyretin |
| Q34100591 | Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering |
| Q38725000 | Stabilization, Assembly, and Toxicity of Trimers Derived from Aβ. |
| Q34590706 | Stable and metastable states of human amylin in solution. |
| Q36444194 | Steric Crowding of the Turn Region Alters the Tertiary Fold of Amyloid-β18-35 and Makes It Soluble. |
| Q42198100 | Structural Insight into an Alzheimer's Brain-Derived Spherical Assembly of Amyloid β by Solid-State NMR |
| Q24631702 | Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils |
| Q36967253 | Structural insights into Aβ42 oligomers using site-directed spin labeling |
| Q48046294 | Structural properties of amyloid β(1-40) dimer explored by replica exchange molecular dynamics simulations. |
| Q38549882 | Structural, morphological, and functional diversity of amyloid oligomers |
| Q35657526 | Structure-based design of conformation- and sequence-specific antibodies against amyloid β. |
| Q37207738 | Structures of oligomers of a peptide from β-amyloid |
| Q45991189 | Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone. |
| Q42127485 | Synthetic dimeric Aβ(28-40) mimics the complex epitope of human anti-Aβ autoantibodies against toxic Aβ oligomers |
| Q44432291 | The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization |
| Q91583280 | The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer's Disease |
| Q33801791 | The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency. |
| Q24294387 | The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway |
| Q37774042 | The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? |
| Q35194588 | The elusive nature and diagnostics of misfolded Aβ oligomers |
| Q42085979 | The off-rate of monomers dissociating from amyloid-β protofibrils |
| Q39924452 | The structure of chromophore-grafted amyloid-β(12-28) dimers in the gas-phase: FRET-experiment guided modelling |
| Q27670496 | Towards a Pharmacophore for Amyloid |
| Q38505323 | Toxic species in amyloid disorders: Oligomers or mature fibrils |
| Q44808414 | Transformation of amyloid β(1-40) oligomers into fibrils is characterized by a major change in secondary structure |
| Q33845519 | Transient formation of intermediate conformational states of amyloid-β peptide revealed by heteronuclear magnetic resonance spectroscopy |
| Q36303460 | Turn nucleation perturbs amyloid β self-assembly and cytotoxicity |
| Q55509540 | X-ray Crystallographic Structure of a Compact Dodecamer from a Peptide Derived from Aβ16-36. |
| Q27682495 | X-ray Crystallographic Structures of Trimers and Higher-Order Oligomeric Assemblies of a Peptide Derived from Aβ 17–36 |
| Q36797995 | X-ray Crystallographic Structures of a Trimer, Dodecamer, and Annular Pore Formed by an Aβ17-36 β-Hairpin |
| Q36981493 | hESC-secreted proteins can be enriched for multiple regenerative therapies by heparin-binding |
| Q21558493 | β-hairpin-mediated formation of structurally distinct multimers of neurotoxic prion peptides |
Search more.